Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emerging Biopharma
Biotech
Biotech unit Pfizer Ignite flames out
Pfizer is snuffing out its program designed to incubate new innovations from select companies, dubbed Pfizer Ignite.
Gabrielle Masson
Mar 12, 2026 3:58pm
French biotech pens $128M deal for Kezar protein degrader work
Mar 12, 2026 9:00am
Atrium arises from Avidity buyout with $270M, preclinical assets
Feb 27, 2026 11:05am
Harbour sails with Solstice in $1.1B biobucks deal
Feb 24, 2026 2:38pm
New biotech Slate aims to solve migraine injection equation
Feb 24, 2026 7:30am
Korsana crosses into crowded Alzheimer's field with $175M
Feb 18, 2026 6:00am
More News
Priovant will move brepocitinib to phase 3 after midstage win
Feb 6, 2026 7:00am
Fortitude has faith glue degraders can beat ADC resistance
Jan 26, 2026 10:47am
J. Craig Venter launches genomics startup
Jan 23, 2026 8:50am
Corxel secures $287M series D to fund oral GLP-1 studies
Jan 22, 2026 10:22am
See more stories